Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer - Concepedia

Concepedia

Publication | Open Access

Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer

DOI Full Paper Access

11

Citations

23

References

2024

Year

Chiharu Sako, Chong Duan, Kevin Maresca, Sean Kent, Taly Gilat Schmidt, Hugo J.W.L. Aerts, Ravi B. Parikh, George R. Simon, Petr Jordan

JCO Clinical Cancer Informatics

Abstract

The study developed and validated a deep learning radiomic biomarker using pretreatment routine CT/PET-CT scans to identify ICI benefit in advanced NSCLC.

References

	Year	Citations

Page 1